Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial

NCT01858545 is registered in ClinicalTrials.gov with Integra LifeSciences Corporation as lead sponsor.

NCT NCT01858545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01858545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Lead sponsor
Integra LifeSciences Corporation
Phase
Not applicable
Overall status
Terminated
Start date
May 31, 2013
Completion date
December 31, 2015
Enrollment
56 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

foot ulcer, diabetic